We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8015:TSEToyota Tsusho Corp. Analysis

Data as of 2026-06-11 - not real-time

¥5,969.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at ¥5,969, below its 20‑day (¥6,673) and 50‑day (¥6,525) simple moving averages but still above the 200‑day SMA (¥5,495), indicating short‑term weakness within a longer‑term uptrend. RSI sits at 33, flagging oversold conditions, while the MACD remains bearish, suggesting a potential near‑term bounce from the support level of ¥5,816. Volume is increasing and the technical trend is marked bullish, aligning with the “Extreme Greed” market sentiment (85.57).
Fundamentally, revenue growth of 19.5% and a PE of 17 versus the industry average of 30 portray relative cheapness, yet the DCF fair value of ~¥4,233 indicates the stock is currently overvalued. The dividend yield of 2.07% with a 34% payout ratio appears sustainable given strong operating cash flow and modest net debt. High 30‑day volatility (~53%) is tempered by a low beta (0.69), and the diversified conglomerate model reduces sector‑specific risk, supporting a balanced “blend” investment case.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Oversold RSI indicating near‑term price rebound
  • Support level at ¥5,816 providing downside cushion
  • Increasing volume supporting bullish momentum

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong 19.5% revenue growth and low PE relative to peers
  • Sustainable 2.07% dividend yield with modest payout ratio
  • Analyst target median price of ¥7,800 suggesting upside

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Diversified conglomerate business reducing sector concentration risk
  • Dividend sustainability backed by solid cash flow
  • Current price above DCF fair value raising valuation concerns

Key Metrics & Analysis

Financial Health

Revenue Growth19.50%
Profit Margin3.21%
P/E Ratio17.0
ROE13.20%
ROA4.42%
Debt/Equity65.70
P/B Ratio2.0
Op. Cash Flow¥461.2B
Free Cash Flow¥177.2B
Industry P/E30.3

Technical Analysis

TrendBullish
RSI33.3
Support¥5,816.00
Resistance¥7,559.00
MA 20¥6,672.75
MA 50¥6,525.30
MA 200¥5,495.13
MACDBearish
VolumeIncreasing
Fear & Greed Index85.57

Valuation

Fair Value¥4,232.80
Target Price¥7,726.25
Upside/Downside29.44%
GradeOvervalued
TypeBlend
Dividend Yield2.07%

Risk Assessment

Beta0.69
Volatility52.89%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.